Stroke
📧 Sign up to get email alerts when something new happens for Stroke.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-06-11FDA Approved: CLOPIDOGREL — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application to authorize a generic clopidogrel bisulfate product from Aurobindo Pharma Limited.
-
FDA approval · 2014-04-11FDA Approved: CLOPIDOGREL — Original Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals LLC's original application for clopidogrel, enabling a generic version of the antiplatelet medicatio…
-
FDA approval · 2014-03-04FDA Approved: CLOPIDOGREL — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s original generic application for clopidogrel bisulfate (clopidogrel).
-
FDA approval · 2013-12-12FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for Plavix (clopidogrel) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2013-10-30FDA Approved: BRILINTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for BRILINTA (ticagrelor) submitted by AstraZeneca Pharmaceuticals LP.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-08-05FDA Approved: CERETEC — Supplemental Application (Medi-Physics Inc. dba GE Healthcare.)
FDA approves a supplemental application for CERETEC (TECHNETIUM TC-99M EXAMETAZIME) from Medi-Physics Inc. dba GE Healthcare.
-
FDA approval · 2013-06-11FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Losartan Potassium submitted by Aurobindo Pharma Limited.
-
FDA approval · 2013-04-04FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Inc)
The FDA approved a supplemental application for clopidogrel bisulfate submitted by Dr. Reddy's Laboratories Inc, for their generic clopidogr…
-
FDA approval · 2012-12-20FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Losartan Potassium from Aurobindo Pharma Limited, resulting in approval of a generic losartan po…
-
FDA approval · 2012-12-19FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for Losartan Potassium submitted by Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2012-09-28FDA Approved: COZAAR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Cozaar (losartan potassium) filed by Organon LLC.
-
FDA approval · 2012-09-18FDA Approved: LOSARTAN POTASSIUM TABLETS, 25 MG — Original Application (Jubilant Cadista Pharmaceuticals Inc.)
The FDA approves Jubilant Cadista's Losartan Potassium tablets 25 mg as an original ANDA, providing a generic version of losartan for hypert…
-
FDA approval · 2012-05-17FDA Approved: CLOPIDOGREL BISULFATE — Original Application (Dr.Reddy's Laboratories Inc)
FDA approved Dr. Reddy's Laboratories' clopidogrel bisulfate as an original application (ANDA), enabling a generic version of the antiplatel…
-
FDA approval · 2012-05-17FDA Approved: CLOPIDOGREL — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's generic clopidogrel; an antiplatelet agent used to reduce cardiovascular events in patients with acute coronary syndrome…
-
FDA approval · 2012-05-17FDA Approved: CLOPIDOGREL — Original Application (Aurobindo Pharma Limited)
FDA approves Aurobindo Pharma Limited's Original Application for clopidogrel bisulfate, enabling a generic version of clopidogrel to be mark…
-
FDA approval · 2012-04-18FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approval of a supplemental application for clopidogrel bisulfate submitted by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2011-07-20FDA Approved: BRILINTA — Original Application (AstraZeneca Pharmaceuticals LP)
FDA approved Brilinta (ticagrelor) through an original application for use in patients with acute coronary syndrome to reduce the risk of ca…
-
FDA approval · 2010-10-06FDA Approved: LOSARTAN POTASSIUM — Original Application (AiPing Pharmaceutical, Inc.)
FDA approved AiPing Pharmaceutical, Inc.'s Losartan Potassium as an original application generic, authorizing the same uses as the reference…
-
FDA approval · 2010-10-06FDA Approved: LOSARTAN POTASSIUM — Original Application (Quallent Pharmaceuticals Health LLC)
The FDA approved Quallent Pharmaceuticals Health LLC's generic Losartan Potassium under an original ANDA (ANDA078243).
-
FDA approval · 2010-05-18FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's supplemental application for clopidogrel bisulfate, a generic version of clopidogrel. The ap…
-
FDA approval · 2009-10-29FDA Approved: RAMIPRIL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA granted supplemental approval for Lupin Pharmaceuticals’ ramipril generic under the ANDA, authorizing continued marketing of the product…
-
FDA approval · 2009-04-03FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for simvastatin from NorthStar Rx LLC under ANDA 077691, granting approval for a change to the gener…
-
FDA approval · 2008-06-20FDA Approved: RAMIPRIL — Original Application (GSMS, Incorporated)
FDA approved RAMIPRIL as a generic drug under an original Abbreviated New Drug Application (ANDA 079116) filed by GSMS, Incorporated.
-
FDA approval · 2008-01-14FDA Approved: CLOPIDOGREL BISULFATE — Original Application (Dr.Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's clopidogrel bisulfate tablet under an Original Application (ANDA076273). The approval enable…
-
FDA approval · 2007-10-22FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approves a supplemental application for Plavix (clopidogrel) submitted by Sanofi-Aventis U.S. LLC.